Target Market

Target users:

Orthopedic practitioners, working in hospitals or other types of clinics that usually treat patients who suffer from osteomyelitis.

Target initial market:

USA, EC and Israel. It is estimated that in the target market the number of cases that can be treated by OID per year is more than one million. The cost of OM treatment today per case is more than 30,000$.

Target secondary market:

Developing countries. It is estimated that in the secondary target market there are more than five million cases per year to be treated by OrthoIon. The low cost of OID kit makes it ideal for use in those regions.